Abstract
Parkinsons disease (PD) is clinically characterized by symptoms of akinesia, rigidity, and resting tremor, which are related to a dopaminergic deficiency of the nigrostriatal pathway. Disorders of gait are common symptoms of PD that affect the quality of life in these patients. One of the main focuses of physical rehabilitation in PD is to improve the gait deficits in the patients. In the last decade, a small number of studies have investigated the use of the treadmill for the rehabilitation of gait in PD patients. Although, the results of these studies are promising, the mechanisms underlying the therapeutic effect of the treadmill in PD are still largely unknown. This paper reviews 10 years of investigation of treadmill training in PD, focusing on the possible mechanisms involved in the therapeutic effect of the treadmill. Understanding these mechanisms may improve the prescription and design of physical therapy programs for PD patients.
Keywords: gait, mechanisms, Parkinson's disease, sensory cues, neurorehabilitation, neuroplasticity, physical therapy, treadmill, Parkinson
Current Aging Science
Title: How Does the Treadmill Affect Gait in Parkinsons Disease?
Volume: 5 Issue: 1
Author(s): Olalla Bello and Miguel Fernandez-Del-Olmo
Affiliation:
Keywords: gait, mechanisms, Parkinson's disease, sensory cues, neurorehabilitation, neuroplasticity, physical therapy, treadmill, Parkinson
Abstract: Parkinsons disease (PD) is clinically characterized by symptoms of akinesia, rigidity, and resting tremor, which are related to a dopaminergic deficiency of the nigrostriatal pathway. Disorders of gait are common symptoms of PD that affect the quality of life in these patients. One of the main focuses of physical rehabilitation in PD is to improve the gait deficits in the patients. In the last decade, a small number of studies have investigated the use of the treadmill for the rehabilitation of gait in PD patients. Although, the results of these studies are promising, the mechanisms underlying the therapeutic effect of the treadmill in PD are still largely unknown. This paper reviews 10 years of investigation of treadmill training in PD, focusing on the possible mechanisms involved in the therapeutic effect of the treadmill. Understanding these mechanisms may improve the prescription and design of physical therapy programs for PD patients.
Export Options
About this article
Cite this article as:
Bello Olalla and Fernandez-Del-Olmo Miguel, How Does the Treadmill Affect Gait in Parkinsons Disease?, Current Aging Science 2012; 5 (1) . https://dx.doi.org/10.2174/1874609811205010028
DOI https://dx.doi.org/10.2174/1874609811205010028 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Integrin α4β7 Antagonists: Activities, Mechanisms of Action and Therapeutic Prospects
Current Immunology Reviews (Discontinued) Upregulated Long Non-coding RNA ALMS1-IT1 Promotes Neuroinflammation by Activating NF-κB Signaling in Ischemic Cerebral Injury
Current Pharmaceutical Design Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
Current Pharmaceutical Design Detection of the Artery of Adamkiewicz Before Open Surgery and Endovascular Aortic Repair: A Review
Current Medical Imaging Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases
Current Signal Transduction Therapy Biomaterial and Stem Cell Interactions: Histological Biocompatibility
Current Stem Cell Research & Therapy Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point
Current Drug Targets Research Advancements in Porcine Derived Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Targeting ADAM12 in Human Disease: Head, Body or Tail?
Current Pharmaceutical Design Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders
CNS & Neurological Disorders - Drug Targets Alzheimer's disease: Targeting the Cholinergic System
Current Neuropharmacology Paraneoplastic Neurological Syndromes - Diagnosis and Management
Current Pharmaceutical Design The DREAM of Pain Relief
Current Rheumatology Reviews Frequency of Depression and its Correlation with Serum Carnitine Level in HIV/AIDS Patients
Current HIV Research Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson’s Disease: Bridging Molecular Studies and Clinical Trials
CNS & Neurological Disorders - Drug Targets Expression of Opioid Receptors During Peripheral Inflammation
Current Topics in Medicinal Chemistry The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury
Current Stem Cell Research & Therapy Lysosomal Storage Diseases and the Blood-Brain Barrier
Current Pharmaceutical Design The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease
Current Alzheimer Research Modern Approaches to Tissue Engineering of the Spinal Cord: Analytical Review
Current Regenerative Medicine (Discontinued)